← Back to Stock Screener← Stock Screener

ZYBERNO

Stock Report

Updated Jun 5, 2026

Quipt Home Medical Corp. (QIPT)

Healthcare • NASDAQ

$3.65

Professional Investment Analysis

ZYBERNO SCORE →

Is it a great business? Is it getting better?

36.0/100

WEAK BUSINESS

Quipt Home Medical Corp. (QIPT) scores 36/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.

📊 How is the Zyberno Score calculated? +

The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.

The 4 Core Categories (25 points each):

1. PROFITABILITY (25 pts)

Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent

2. FINANCIAL STRENGTH (25 pts)

Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe

3. CASH FLOW QUALITY (25 pts)

Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)

4. GROWTH & CONSISTENCY (25 pts)

Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good

Score Interpretation:

75-100

GREAT BUSINESS

65-74

GOOD BUSINESS

50-64

AVERAGE BUSINESS

30-49

WEAK BUSINESS

0-29

POOR BUSINESS

→ View full QIPT quality analysis & detailed breakdown

VALUATION SIGNAL

MARGIN OF SAFETY

Is this stock cheap or expensive relative to what the business has historically generated for owners?

+100.0%

Undervalued

Growth gap unavailable — insufficient data for reverse DCF calculation.

🎯 Expected Annual Return →

649.6%

5-year annualised assuming price converges to intrinsic value

💰 How is Margin of Safety calculated? +

Margin of Safety measures how much discount or premium you're paying relative to a stock's intrinsic value. It's Benjamin Graham's core principle: the larger the margin, the lower your downside risk.

Formula: (Intrinsic Value − Current Price) ÷ Intrinsic Value × 100%

How We Calculate Intrinsic Value (DCF Method):

Step 1: Calculate current Owner Earnings (OCF − Maintenance CapEx)

Step 2: Calculate company-specific growth rate using log-linear regression on 16 quarters of Owner Earnings

Step 3: Project 10 years forward using the calculated growth rate

Step 4: Discount each year's cash flow to present value using 10% discount rate

Step 5: Calculate terminal value using 3% perpetual growth rate

Step 6: Sum all discounted cash flows = Intrinsic Value

What The Percentages Mean:

+50% or more

EXCELLENT — Very undervalued

+25% to +50%

GOOD — Attractive discount

0% to +25%

FAIR — Reasonable value

0% to -25%

CAUTION — Slight premium

-25% or worse

POOR — Overvalued

"Price is what you pay, value is what you get." — Warren Buffett

→ View full QIPT valuation analysis · → View full QIPT Brina Gap analysis

📈 How is Brina Gap calculated? +

Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in.

Formula: Fundamental Growth Rate − Market-Implied Growth Rate

The Two Components:

Fundamental Growth Rate = ROIC × Reinvestment Rate

What the business can sustainably grow at based on how much it reinvests and what return it earns on that capital. Grounded in historical financials.

Market-Implied Growth Rate = Reverse DCF

The growth rate the current Enterprise Value implicitly assumes. Calculated by back-solving a 10-year DCF model (10% WACC, 3% terminal growth) until the present value of projected cash flows equals EV.

What The Gap Means:

Gap > +5% Market Underestimates — potential upside

+2% to +5% Slight Underestimate

-2% to +2% Fairly Priced — market consensus matches fundamentals

-5% to -2% Slight Overestimate

Gap < -5% Market Overestimates — price embeds optimism fundamentals don't support

A positive gap (market underestimates) combined with a positive Margin of Safety is the strongest combined signal — the business is both cheap historically and forward economics are stronger than the price suggests.

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-9.9%)

Debt-to-Equity (Solvency Risk):AVERAGE (0.92x)

Operating Margin (Operational Efficiency):CRITICAL (-1.2%)

Return on Capital (Capital Efficiency):CRITICAL (-1.0%)

📊 Valuation Trilogy

Three interconnected metrics for complete valuation analysis

Click any metric for full methodology and detailed analysis

Zyberno's Verdict

Quipt Home Medical Corp. (QIPT) stock report — Zyberno Score 36/100 (WEAK BUSINESS), Margin of Safety +100.0%, 650% expected annual return. Full financial analysis on Zyberno.

According to Zyberno's DCF model, Quipt Home Medical Corp. (QIPT) trades at $3.65 against an estimated intrinsic value per share of $32,941.00 — a +100.0% Margin of Safety based on Owner Earnings of $26.59M TTM, projected at 21.3% growth for 10 years with a 2.5% terminal growth rate. Zyberno's model translates this into a 5-year expected return of 649.6% annually.

Over the trailing twelve months, QIPT generated $26.59M in Owner Earnings. Capital was deployed as follows: $130.00K returned via share buybacks, $10.75M invested in capital expenditures. Reinvestment rate: 464.2%. Owner Earnings have grown at 21.3% annually over the trailing five years using log-linear regression.

DIVISION I: EXECUTIVE SUMMARY

A. Market Valuation

Market Price & Capitalization (2)

Current Price:3.65

Market Cap:$159.17K

Valuation Multiples (3)

P/B Ratio:0.00x

P/S Ratio:0.00x

Peg Ratio:-999.00x

Enterprise Metrics (3)

Enterprise Value:$120.78M

Ev Ebitda Ratio:2.50x

Pfcf Ratio:0.01x

B. Profitability Assessment

Return Metrics (5)

ROE:

-9.9%

📊 Click to view full QIPT ROE analysis →

ROA:-4.1%

Roic:

-1.0%

📊 Click to view full QIPT ROIC analysis →

Reinvestment Rate:464.2%

Fundamental Growth Rate (g):-4.8%

Margin Analysis (3)

Operating Margin Ttm:-1.2%

Net Margin Ttm:-4.0%

Ebitda Margin:18.2%

TTM Performance (3)

Gross Margin Ttm:72.4%

Operating Margin Ttm:-1.2%

Net Margin Ttm:-4.0%

Yield Metrics (3)

Earnings Yield:-$6.30

Owner Earnings Yield:$16.70K

Dividend Yield:0.0%

C. Log-Linear Regression Growth Trends

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):34.0%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):21.4%

Operating Cash Flow Growth Rate (Linear):0.4%

D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.04x

Quick Ratio:0.68x

Cash Ratio:0.14x

Leverage Analysis (3)

Debt To Equity Ttm:0.92x

Debt-to-Equity Ratio:0.92x

Debt To Ebitda:2.71x

Coverage Ratios (2)

Interest Coverage Ratio:-0.56x

Times Interest Earned:-0.56

Capital Structure (4)

Working Capital:2,868,000.00

Cash And Cash Equivalents:10,543,000.00

Long Term Debt:$84.00M

Net Debt:$120.62M

DIVISION II: FINANCIAL STATEMENTS ANALYSIS

A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $264.97M

Linear Growth: 34.0%

📊 Click to view full QIPT Revenue analysis & methodology →

Cost Of Revenue Ttm:$73.19M

Profitability Breakdown (2)

Gross profit TTM: $191.78M

Linear Growth: 32.6%

📊 Click to view full QIPT Gross Profit analysis & methodology →

-$3.25M

Bottom Line Performance (3)

-$10.67M

Income Before Tax:-$9.97M

Ebitda Ttm:48,343,000.00

Operating Expenses (5)

Operating Expenses:0.00

R And D Expense:0.00

Sga Expense:0.00

Income Tax Expense:$236.00K

Interest Expense:6,805,000.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%

Sga To Revenue Percentage:0.0%

Ebitda Margin:18.2%

B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$280.66M

Current Assets:$78.11M

Ppe Net:45,874,000.00

Goodwill:61,560,000.00

Intangible Assets:$75.89M

Liability Structure (4)

Total Liabilities:167,663,000.00

Current Liabilities:75,239,000.00

Long Term Debt:$84.00M

Short Term Debt:$47.17M

Equity & Capital (3)

Equity:$112.99M

Retained Earnings:-$182.33M

Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:34,920,000.00

Inventory:26,922,000.00

Accounts Payable:38,551,000.00

Special Items (2)

Contract Liabilities:0.00

Stock Based Compensation:982,000.00

C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $37.33M

Linear Growth: 39.0%

Free cash flow TTM: $26.59M

Linear Growth: 21.4%

📊 Click to view full QIPT Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:-$1.95M

Capital Expenditures Ttm:10,747,000.00

Financing Activities (3)

Financing Cash Flow:-$9.44M

Dividends Paid Ttm:0.00

Stock Repurchase:130,000.00

Capital Transactions (3)

Common Stock Issuance:30,582,362.50

Long Term Debt Issuance:$0.00

Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:51,590,000.00

DIVISION III: OPERATIONAL METRICS

A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.23

-$0.23

Earnings Per Share Ttm:-$244.67

Revenue & Cash Per Share (3)

Sales Per Share Ttm:6,076.13

Operating Cash Flow Per Share:$864.32

Fcf Per Share Ttm:609.64

Book Value & Capital (2)

Book Value Per Share:$2.59K

Cash Per Share:241.76

Dividend Policy (1)

Dividend Payout Ratio:-999.00x

B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.01x

Working Capital Turnover Ttm:92.39x

Receivables Management (2)

Receivables Turnover Ttm:7.59x

Days Sales Outstanding Ttm:48.10

Inventory Management (2)

Inventory Turnover Ttm:2.72x

Days Inventory Outstanding Ttm:134.26

Payables & Cash Cycle (2)

Days Payable Outstanding:192.25

Cash Conversion Cycle:-9.89

C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00

Quality Score:40.00

Market Metrics (2)

Beta:0.00x

Volatility Category:unknown

DIVISION IV: INVESTMENT ANALYSIS

A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $26.59M

Linear Growth: 21.3%

📊 Click to view full QIPT Owner Earnings analysis & methodology →

Owner Earnings Per Share:$609.64

Owner Earnings Yield:$16.70K

Growth Assessment (1)

Owner Earnings Growth Rate:$21.27

Damodaran Growth Analysis (2)

Reinvestment Rate:464.2%

Fundamental Growth Rate (g):-4.8%

Intrinsic Value Models (1)

Intrinsic Value:

$1.44B

📊 Click to view full QIPT DCF valuation →

Margin of Safety (1)

Margin Of Safety:

100.0%

📊 Click to view full QIPT valuation analysis →

Return Scenarios (1)

Theoretical 5-Year Return:

649.6%

📊 Click to view full QIPT expected return analysis →

Investment Assessment (1)

Buffett Assessment:Excellent margin of safety

B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):34.0%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):21.4%

Operating Cash Flow Growth Rate (Linear):0.4%

Other Growth Rates (3)

Gross Profit Growth Rate (Linear):32.6%

Book Value Growth Rate (Linear):8.4%

Owner Earnings Growth Rate:$21.27

C. Company Profile & Context

Corporate Information (6)

Symbol:QIPT

Company Name:Quipt Home Medical Corp.

Sector:Healthcare

Industry:Services-Misc Health & Allied Services, NEC

Exchange:NASDAQ

Country:United States

Market Classification (3)

Market Cap Category:N/A

Price Category:low

Volume Category:N/A

Share Structure (3)

Shares Outstanding:43.61K

Shares Outstanding Basic:43.61K

Shares Outstanding Diluted:43.61K

Data Processing Info (3)

Processing Version:v3.0

Last Updated:2026-06-05 21:24:18 UTC

Data Timestamp:2026-06-05T21:24:18.524020